Literature DB >> 16806050

Modeling human mitochondrial diseases in flies.

Alvaro Sánchez-Martínez1, Ningguang Luo, Paula Clemente, Cristina Adán, Rosana Hernández-Sierra, Pilar Ochoa, Miguel Angel Fernández-Moreno, Laurie S Kaguni, Rafael Garesse.   

Abstract

Human mitochondrial diseases are associated with a wide range of clinical symptoms, and those that result from mutations in mitochondrial DNA affect at least 1 in 8500 individuals. The development of animal models that reproduce the variety of symptoms associated with this group of complex human disorders is a major focus of current research. Drosophila represents an attractive model, in large part because of its short life cycle, the availability of a number of powerful techniques to alter gene structure and regulation, and the presence of orthologs of many human disease genes. We describe here Drosophila models of mitochondrial DNA depletion, deafness, encephalopathy, Freidreich's ataxia, and diseases due to mitochondrial DNA mutations. We also describe several genetic approaches for gene manipulation in flies, including the recently developed method of targeted mutagenesis by recombinational knock-in.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806050      PMCID: PMC4853902          DOI: 10.1016/j.bbabio.2006.05.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  64 in total

1.  The highly compact structure of the mitochondrial DNA polymerase genomic region of Drosophila melanogaster: functional and evolutionary implications.

Authors:  E Lefai; M A Fernández-Moreno; L S Kaguni; R Garesse
Journal:  Insect Mol Biol       Date:  2000-06       Impact factor: 3.585

2.  Ends-out, or replacement, gene targeting in Drosophila.

Authors:  Wei J Gong; Kent G Golic
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

Review 3.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 4.  The neurology of mitochondrial DNA disease.

Authors:  Robert McFarland; Robert W Taylor; Douglass M Turnbull
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

Review 5.  Genome manipulation by homologous recombination in Drosophila.

Authors:  Xiaolin Bi; Yikang S Rong
Journal:  Brief Funct Genomic Proteomic       Date:  2003-07

6.  RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila.

Authors:  Peter R Anderson; Kim Kirby; Arthur J Hilliker; John P Phillips
Journal:  Hum Mol Genet       Date:  2005-10-03       Impact factor: 6.150

7.  Mutations in the spacer region of Drosophila mitochondrial DNA polymerase affect DNA binding, processivity, and the balance between Pol and Exo function.

Authors:  Ningguang Luo; Laurie S Kaguni
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

8.  Frataxin deficiency and mitochondrial dysfunction.

Authors:  Massimo Pandolfo
Journal:  Mitochondrion       Date:  2002-11       Impact factor: 4.160

9.  The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit.

Authors:  Sherine S L Chan; Matthew J Longley; William C Copeland
Journal:  J Biol Chem       Date:  2005-07-16       Impact factor: 5.157

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  16 in total

Review 1.  Modeling mitochondrial encephalomyopathy in Drosophila.

Authors:  Michael J Palladino
Journal:  Neurobiol Dis       Date:  2010-05-21       Impact factor: 5.996

2.  Invertebrate models for coenzyme q10 deficiency.

Authors:  Daniel J M Fernández-Ayala; Sandra Jiménez-Gancedo; Ignacio Guerra; Plácido Navas
Journal:  Mol Syndromol       Date:  2014-07

Review 3.  Drosophila melanogaster: An emerging model of transgenerational effects of maternal obesity.

Authors:  Rita T Brookheart; Jennifer G Duncan
Journal:  Mol Cell Endocrinol       Date:  2015-12-11       Impact factor: 4.102

4.  An inventory of peroxisomal proteins and pathways in Drosophila melanogaster.

Authors:  Joseph E Faust; Avani Verma; Chengwei Peng; James A McNew
Journal:  Traffic       Date:  2012-07-25       Impact factor: 6.215

5.  Mislocalization of mitochondria and compromised renal function and oxidative stress resistance in Drosophila SesB mutants.

Authors:  Selim Terhzaz; Pablo Cabrero; Venkateswara R Chintapalli; Shireen-A Davies; Julian A T Dow
Journal:  Physiol Genomics       Date:  2009-12-15       Impact factor: 3.107

Review 6.  Modeling dietary influences on offspring metabolic programming in Drosophila melanogaster.

Authors:  Rita T Brookheart; Jennifer G Duncan
Journal:  Reproduction       Date:  2016-09       Impact factor: 3.906

7.  Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogaster.

Authors:  Jian Chen; Xiaoying Shi; Ranjani Padmanabhan; Qiong Wang; Zhidan Wu; Susan C Stevenson; Marc Hild; Dan Garza; Hao Li
Journal:  Genome Res       Date:  2007-11-27       Impact factor: 9.043

8.  NAD supplementation improves mitochondrial performance of cardiolipin mutants.

Authors:  Jiajia Ji; Deena Damschroder; Denise Bessert; Pablo Lazcano; Robert Wessells; Christian A Reynolds; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-01-18       Impact factor: 4.698

9.  A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders.

Authors:  Fred D Mast; Jing Li; Maninder K Virk; Sarah C Hughes; Andrew J Simmonds; Richard A Rachubinski
Journal:  Dis Model Mech       Date:  2011-06-13       Impact factor: 5.758

10.  Mitochondrial genome deletions and minicircles are common in lice (Insecta: Phthiraptera).

Authors:  Stephen L Cameron; Kazunori Yoshizawa; Atsushi Mizukoshi; Michael F Whiting; Kevin P Johnson
Journal:  BMC Genomics       Date:  2011-08-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.